Tocilizumab for refractory severe immune checkpoint inhibitor-associated myocarditis.

Détails

ID Serval
serval:BIB_36FA44B46F63
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Tocilizumab for refractory severe immune checkpoint inhibitor-associated myocarditis.
Périodique
Annals of oncology
Auteur⸱e⸱s
Doms J., Prior J.O., Peters S., Obeid M.
ISSN
1569-8041 (Electronic)
ISSN-L
0923-7534
Statut éditorial
Publié
Date de publication
09/2020
Peer-reviewed
Oui
Volume
31
Numéro
9
Pages
1273-1275
Langue
anglais
Notes
Publication types: Letter ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Mots-clé
CS, Corticosteroids, ICIs, Immune-checkpoint inhibitors, IS, Immunosuppressant drugs, MMF, Mycophenolate mofetil, Myocarditis, PET/CT, Positron emission tomography/computed tomography, TCZ, Tocilizumab, checkpoint inhibitors, irAEs, Immune-related adverse events, life-threatening immune-related adverse events
Pubmed
Web of science
Open Access
Oui
Création de la notice
14/06/2020 20:21
Dernière modification de la notice
22/12/2020 7:25
Données d'usage